22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs January 23, 2023
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation July 31, 2024